GRAIL, Inc. Investment Income, Interest
GRAIL, Inc. (GRAL) reported Investment Income, Interest of $7.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- GRAIL, Inc. investment income, interest for the quarter ending 2026-06-30 was $7.23M, a 6.18% increase year-over-year.
- GRAIL, Inc. investment income, interest for the quarter ending 2026-03-31 was $7.99M, a 2.66% increase year-over-year.
- GRAIL, Inc. investment income, interest for the quarter ending 2025-12-31 was $7.96M, a 15.04% decline year-over-year.
- GRAIL, Inc. investment income, interest for the quarter ending 2025-09-30 was $6.11M, a 47.63% decline year-over-year.
- GRAIL, Inc. investment income, interest for fiscal 2025 was $28.65M, a 7.18% increase from fiscal 2024.
- GRAIL, Inc. investment income, interest for fiscal 2024 was $26.73M, a 236.10% increase from fiscal 2023.
- GRAIL, Inc. investment income, interest for fiscal 2023 was $7.95M, a 357.13% increase from fiscal 2023.
- GRAIL, Inc. investment income, interest for fiscal 2023 was $1.74M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.23M 10-Q · filed 2026-08-06 | $15.22M 10-Q · filed 2026-08-06 | $23.17M derived: sum of 3 quarters · filed 2026-08-06 | $29.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.99M 10-Q · filed 2026-05-07 | $15.94M derived: sum of 2 quarters · filed 2026-05-07 | $22.05M derived: sum of 3 quarters · filed 2026-05-07 | $28.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $14.06M derived: sum of 2 quarters · filed 2026-03-12 | $20.87M derived: sum of 3 quarters · filed 2026-08-06 | $28.65M 10-K · filed 2026-03-12 |
| 2025-09-30 | $6.11M 10-Q · filed 2025-11-13 | $12.92M derived: sum of 2 quarters · filed 2026-08-06 | $20.70M 10-Q · filed 2025-11-13 | $30.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $6.81M 10-Q · filed 2026-08-06 | $14.59M 10-Q · filed 2026-08-06 | $23.95M derived: sum of 3 quarters · filed 2026-08-06 | $35.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.78M 10-Q · filed 2026-05-07 | $17.14M derived: sum of 2 quarters · filed 2026-05-07 | $28.81M derived: sum of 3 quarters · filed 2026-05-07 | $31.61M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $21.03M derived: sum of 2 quarters · filed 2026-03-12 | $23.83M derived: sum of 3 quarters · filed 2026-03-12 | $26.73M 10-K · filed 2026-03-12 |
| 2024-09-30 | $11.66M 10-Q · filed 2025-11-13 | $14.47M derived: sum of 2 quarters · filed 2025-11-13 | $17.37M 10-Q · filed 2025-11-13 | $18.72M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $2.81M 10-Q · filed 2025-08-13 | $5.71M 10-Q · filed 2025-08-13 | $7.06M derived: sum of 3 quarters · filed 2026-03-12 | $9.59M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $2.90M 10-Q · filed 2025-05-14 | $4.25M derived: sum of 2 quarters · filed 2026-03-12 | $6.78M derived: sum of 3 quarters · filed 2026-03-12 | $8.63M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $3.88M derived: sum of 2 quarters · filed 2026-03-12 | $5.73M derived: sum of 3 quarters · filed 2026-03-12 | $7.95M 10-K · filed 2025-03-05 |
| 2023-10-01 | $2.53M 10-Q · filed 2024-11-13 | $4.38M derived: sum of 2 quarters · filed 2024-11-13 | $6.60M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $1.85M 10-Q · filed 2024-08-13 | $4.07M 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | $1.74M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |